85 filings
6-K
Motif Bio Plc
18 Mar 20
Current report (foreign)
8:15am
6-K
Motif Bio Plc
5 Mar 20
Current report (foreign)
4:15pm
6-K
Motif Bio Plc
29 Jan 20
Current report (foreign)
4:15pm
6-K
Motif Bio Plc
27 Nov 19
Current report (foreign)
6:15am
6-K
Motif Bio Plc
26 Nov 19
Motif Bio plc Announces Voluntary Delisting from the Nasdaq Capital Market
6:15am
6-K
nqw2t zpq7tj
18 Nov 19
Current report (foreign)
9:10am
6-K
xrq411vqf8g fv7rmw
15 Nov 19
Result of General Meeting
6:20am
6-K
1285u2s
12 Nov 19
Current report (foreign)
6:20am
6-K
2i432p74tsan8jzj
25 Oct 19
Current report (foreign)
6:15am
6-K
p0ruw
3 Oct 19
Current report (foreign)
6:10am
6-K
3p7sbta
2 Oct 19
Current report (foreign)
6:10am
6-K
rsqt176unqfv
30 Sep 19
Current report (foreign)
10:01am
6-K
djk35gz nv9s4id
30 Sep 19
Current report (foreign)
9:00am
6-K
snve5uv
3 Sep 19
Motif Bio and Hercules Capital Amend Loan and Security Agreement
4:05pm
6-K
5s2b1n7
1 Aug 19
Motif Bio and Hercules Capital Amend Loan and Security Agreement
7:30am
6-K
mnsst5l5 tok
26 Jul 19
Motif Bio Confirms Meeting Date with U.S. FDA regarding Iclaprim
6:18am
6-K
flzz3iha rz
26 Jul 19
Current report (foreign)
6:17am
6-K
9q131mim0rki1hp520
19 Jul 19
Motif Bio Announces Receipt of Deficiency Notice from Nasdaq
5:00pm
6-K
pb5 edvw8k9n6w59l
15 Jul 19
Motif Bio Submits Meeting Request and Package to the U.S. FDA for Iclaprim
6:10am
6-K
h6desr
6 Jun 19
Motif Bio Announces Path Forward for Iclaprim following Receipt of FDA Meeting Minutes
6:05am